Dog
11,705 reported events
openFDA
Top reactions: Vomiting (1,992) · Lethargy (see also Central nervous system depression in 'Neurological') (1,973) · Hyperkalaemia (1,741) · Elevated serum alkaline phosphatase (SAP) (1,687) · Weight loss (1,478)
United Kingdom — VMD
Trilotab 30 mg Chewable Tablets for Dogs
Authorised animal medicine, recorded in United Kingdom — VMD. This is a neutral reference record and does not provide dosing or veterinary advice.
Reference information only — not veterinary advice and not a dosing source. Always consult a licensed veterinarian before giving any medicine to an animal.
Active substances
Target species
dogs
Authorisation
No. 20916/3005 · POM-V · Anti Hormone Agent
Source
United Kingdom — VMD. Original source.
Other Trilostane medicines
- TRILOCUR 10 MG/ML SUSPENSION BUVABLE POUR CHIENS
- TRILOCUR 50 MG/ML SUSPENSION BUVABLE POUR CHIENS
- TRILORALE 10 MG/ML SUSPENSION BUVABLE POUR CHIENS
- TRILORALE 50 MG/ML SUSPENSION BUVABLE POUR CHIENS
- TRILOTAB 10 MG COMPRIMES A CROQUER POUR CHIENS
- TRILOTAB 120 MG COMPRIMES A CROQUER POUR CHIENS
- TRILOTAB 150 MG COMPRIMES A CROQUER POUR CHIENS
- TRILOTAB 30 MG COMPRIMES A CROQUER POUR CHIENS
Reported adverse events (openFDA)
Spontaneous adverse-event reports that name Trilostane, by species — reported counts, not proven reactions.
Source: openFDA Animal & Veterinary adverse-event reports.
Surveillance reference only — these are spontaneous adverse-event report counts, not proven adverse reactions, not causation and not a measure of any product's risk or safety. Always consult a licensed veterinarian.